title: [Long-term follow-up of thrombolytic treatment of acute infarct in combination with acute and elective revascularization].
abstract: From March 1983 to June 1986 in 206 patients with acute transmural myocardial infarction, combined intravenous and intracoronary therapy with streptokinase was initiated. After intravenous thrombolysis and randomization in two groups we performed a coronary angiography with selective intracoronary lysis. Infarct related vessels still occluded after intracoronary streptokinase application were opened mechanically in group I. In group II we performed additionally a percutaneous transluminal coronary angioplasty (PTCA) after mechanical recanalisation (occluded vessels) or after thrombolysis (open vessels). In 85 of 87 cases in group II, PTCA could be performed in the acute phase. Elective PTCA was performed in 22 patients of group I (21%) and in nine patients of group II (9%). Up to five years after myocardial infarction, coronary artery bypass grafting (CABG) was necessary in 22 patients (21%) of group I and in 23 patients (22%) of group II. Within four weeks after infarction CABG was performed in 32% and 17% of group I and II respectively. The six-year survival rate was 78% in group I and 82% in group II. Taken all patients together, the six-year survival rate was significantly higher (p = 0.002) for those with early reperfusion (less than or equal to 3.5 h). The survival rates of CABG-patients, PTCA-patients and patients without reperfusion were 91%, 74% and 65% respectively. Streptokinase thrombolysis results, combined with acute or elective PTCA and/or coronary bypass surgery, in a high six-year survival rate after acute transmural myocardial infarction. This rate is about 20% higher than ten years ago.
authors.affiliation: II. Medizinische Klinik, Universität Mainz.
authors.forename: M
authors.initials: M
authors.lastname: Spiecker
authors.forename: R
authors.initials: R
authors.lastname: Erbel
authors.forename: C
authors.initials: C
authors.lastname: Diefenbach
authors.forename: M
authors.initials: M
authors.lastname: Haidasch
authors.forename: N
authors.initials: N
authors.lastname: Treese
authors.forename: K J
authors.initials: KJ
authors.lastname: Henrichs
authors.forename: H J
authors.initials: HJ
authors.lastname: Rupprecht
authors.forename: T
authors.initials: T
authors.lastname: Pop
authors.forename: S
authors.initials: S
authors.lastname: Iversen
authors.forename: H
authors.initials: H
authors.lastname: Oelert
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D002423:Cause of Death; D003131:Combined Modality Therapy; D001026:Coronary Artery Bypass; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000401:mortality / Q000628:therapy*; D013300:Streptokinase / Q000008:administration & dosage*; D015996:Survival Rate; D015912:Thrombolytic Therapy
chemical_list: D013300:Streptokinase
vernacular_title: Langzeitverlauf nach thrombolytischer Behandlung des akuten Infarktes in Kombination mit akuter und elektiver Revaskularisation.